Article ID Journal Published Year Pages File Type
3269273 HPB 2013 6 Pages PDF
Abstract
BL remains frequent after liver resection. It has a dramatic impact on patient survival and care costs. Its incidence could be reduced by avoiding the pre‐operative use of bevacizumab, avoiding selective clamping and performing a blue dye test in all resections.
Related Topics
Health Sciences Medicine and Dentistry Endocrinology, Diabetes and Metabolism
Authors
, , , , , ,